[1]皮百木,宋玫侠.PACAP38调控TRPC6表达对糖尿病视网膜病变大鼠的保护作用[J].眼科新进展,2020,40(7):625-630.[doi:10.13389/j.cnki.rao.2020.0143]
　PI Baimu,SONG Meixia.Regulation effect of PACAP38 on TRPC6 expression in diabetic retinopathy rats[J].Recent Advances in Ophthalmology,2020,40(7):625-630.[doi:10.13389/j.cnki.rao.2020.0143]
点击复制

PACAP38调控TRPC6表达对糖尿病视网膜病变大鼠的保护作用/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年7期
页码:
625-630
栏目:
实验研究
出版日期:
2020-07-05

文章信息/Info

Title:
Regulation effect of PACAP38 on TRPC6 expression in diabetic retinopathy rats
作者:
皮百木; 宋玫侠
475000　河南省开封市，开封市中心医院开封眼病医院眼科（皮百木）；450007　河南省郑州市，联勤保障部队第988医院眼科（宋玫侠）
Author(s):
PI Baimu1; SONG Meixia2
1.Department of Ophthalmology, Kaifeng Eye Hospital, Kaifeng Central Hospital, Kaifeng 475000，Henan Province,China
2 .Department of Ophthalmology, Joint Logistics Support Force 988 Hospital, Zhengzhou 450007，Henan Province,China
关键词:
垂体腺苷酸环化酶激活肽-38; 瞬时受体电位通道6; 糖尿病视网膜病变; 视网膜神经节细胞; 大鼠模型
Keywords:
pituitary adenylate cyclase activating peptide;  transient receptor potential channel 6;  diabetic retinopathy;  retinal ganglion cell;  rat model
分类号:
R774
DOI:
10.13389/j.cnki.rao.2020.0143
文献标志码:
A
摘要:
目的　探讨垂体腺苷酸环化酶激活肽-38（pituitary adenylate cyclase-activating peptide-38,PACAP38）在糖尿病视网膜病变（diabetic retinopathy，DR）过程中的视网膜保护是否由瞬时受体电位通道6（TRPC6）介导。方法　将30只SD大鼠随机分为空白对照组和STZ组，每组15只。经单次腹腔注射链脲佐菌素（streptozotocin，STZ）诱发大鼠糖尿病动物模型。根据不同的干预方式，在注射STZ 2周后，一次性向大鼠一眼玻璃体内注射100 μmol·L-1 PACAP38（STZ+ PACAP38组），另一眼注射等量的PBS作为对照（STZ对照组）。采用Western blot和免疫组织化学分析视网膜组织中瞬时受体电位离子通道蛋白6（transient receptor potential channel 6，TRPC6）的表达情况。利用光学相干断层扫描检测各组大鼠的视网膜厚度。将视网膜神经节细胞系RGC-5细胞暴露于高血糖和低氧环境，分别给予PACAP38、TRPC6通道激动剂（OAG）、PAC1受体拮抗剂（PACAP6-38）、TRPC6通道阻滞剂（SKF96365）处理，对照组用完全培养基常规培养，采用MTT法分析不同药物处理对RGC-5细胞活力的影响。结果　与空白对照组大鼠视网膜厚度相比较，STZ对照组视网膜厚度显著增加（P＜0.05），STZ+PACAP38组大鼠视网膜厚度较STZ对照组明显减少（P＜0.05）。免疫组织化学结果显示：与空白对照组相比较，STZ对照组及STZ+PACAP38组大鼠神经节细胞层、内丛状层、内核层和外丛状层中均检测到了TRPC6免疫阳性信号，且STZ对照组TRPC6免疫阳性表达显著高于STZ+PACAP38组（P＜0.05）。Western blot分析显示，STZ组大鼠视网膜TRPC6蛋白表达显著高于STZ+PACAP38组（P＜0.01）。与HG+DFO+OAG组相比，PACAP38与OAG联合处理可显著提高RGC-5细胞活力（均为P＜0.01）。结论　PACAP38可抑制STZ诱导的DR大鼠视网膜增厚，提高体外暴露于高血糖/低氧环境中RGC-5细胞活力，其可能机制是通过调控TRPC6过表达有效逆转了糖尿病大鼠视网膜病变。
Abstract:
Objective　To investigate whether the effect of pituitary adenylate cyclase activating peptide (PACAP38) on retina in diabetic retinopathy (DR) was mediated by transient receptor potential channel 6 (TRPC6). Methods　Thirty SD rats were randomly divided into a normal control group and a streptozotocin (STZ) model group, with 15 in each group. A single intraperitoneal injection of STZ induced an animal model of diabetes in rats. According to different intervention methods, two weeks after STZ injection, 100 μ mol·L-1 PACAP38 (STZ + PACAP38 group) was injected into the vitreous cavity of one eye of rat at one time, and the same amount of PBS was used as a control (STZ group) in the other eye. Western blot and immunohistochemistry were used to analyze the expression of TRPC6 in retinal tissue. Retinal thickness of rats was measured by means of optical coherence tomography. Retinal ganglion cell line (RGC-5 cells) were exposed to hyperglycemia and hypoxia, and were treated with PACAP38, TRPC6 channel agonist (OAG), PAC1 receptor antagonist (PACAP6-38), and TRPC6 channel blocker (SKF96365) respectively, while the normal control group was treat normally in complete medium. The cell viability of each group was analyzed by MTT methods. Results　Compared with the normal control group, the thickness of the retina in the STZ group increased significantly (P<0.05), while the thickness of the retina in the STZ+PACAP38 group was thinner than that in the STZ group (P<0.05). From the results of immunohistochemistry, compared with the control group, TRPC6 immunopositive signals were detected in the ganglion cell layer, inner plexiform layer, inner core layer and outer plexiform layer of the STZ group and STZ + PACAP38 group. The expression of TRPC6 immunopositive signal in STZ group was significantly higher than that in STZ + PACAP38 group (P<0.05). Western blot analysis showed that the expression of TRPC6 protein in STZ group was significantly higher than that in STZ + PACAP38 group (P<0.01). Compared with the HG + DFO + OAG group, the combined treatment of PACAP38 and OAG significantly increased the viability of RGC-5 cells (P<0.01). Conclusions　PACAP38 can inhibit retinal thickening of DR rats induced by STZ, and increase the viability of RGC-5 cells exposed to hyperglycemia/hypoxia in vitro. The possible mechanism is that it can effectively reverse the retinopathy of diabetic rats by regulating TRPC6 overexpression.

参考文献/References:

［1］　CAO D,YANG D,HUANG Z,ZENG Y,WANG J,HU Y,et al.Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy［J］.Acta Diabetol,2018,55(5):469-477.
［2］　D’AMICO A G,MAUGERI G,REITANO R,BULOCO C,SACCONE S,DRAGO F,et al.PACAP modulates expression of hypoxia-inducible factors in streptozotocin--induced diabetic rat retina［J］.J Mol Neurosci,2015,57(4):501-509.
［3］　LAKK M,SZABO B,VOLGYI B,GABRIEL R,DENES V.Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina［J］.Invest Ophthalmol Vis Sci,2012,53(12):7825-7832.
［4］　ISOBE K,YOKOYAMA T,MORIGUCHI-MORI K,KUMAGAI M,SATOH Y I,KUJI A,et al.Role of pituitary adenylyl cyclase-activating polypeptide in intracellular calcium dynamics of neurons and satellite cells in rat superior cervical ganglia［J］.Biomed Res,2017,38(2):99-109.
［5］　颜秋霞,马义.PACAP及其衍生物治疗糖尿病及其并发症的研究进展［J］.中国生物工程杂志,2018,38(1):62-68.
YAN Q X,MA Y.Research progress of pituitary adenylate cyclase-activating polypeptide (PACAP) as a new potential therapeutic peptide in diabetes and its complications［J］.Chin J Biotechnol,2018,38(1):62-68.
［6］　ARREDONDO Z D,NOGUEZ R I,BAUTISTA A C,VAZQUEZ R O,BERNARDINI M,FIORIO P A,et al.Dual contribution of TRPV4 antagonism in the regulatory effect of vasoinhibins on blood-retinal barrier permeability:diabetic milieu makes a difference［J］.Sci Rep,2018,8(1):9652.
［7］　SACHDEVA R,SCHLOTTERER A,SCHUMACHER D,MATKA C,MATKA I,DIETRICH N,et al.TRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulation［J］.Mol Metab,2018,9:156-167.
［8］　ROY A,DERAKHSHAN F,WILSON R J.Stress peptide PACAP engages multiple signaling pathways within the carotid body to initiate excitatory responses in respiratory and sympathetic chemosensory afferents［J］.Am J Physiol Regul Integr Comp Physiol,2013,304(12):R1070-R1084.
［9］　MERRIAM L A,ROMAN C W,BARAN C N,GIRARD B M,MAY V,PARSONS R I.Pretreatment with nonselective cationic channel inhibitors blunts the pacap-induced increase in guinea pig cardiac neuron excitability［J］.J Mol Neurosci,2012,48(3):721-729.
［10］　李立,汤永强.糖尿病大鼠视网膜缺氧诱导因子-1α和血管内皮生长因子的表达［J］.第四军医大学学报,2007，28(7):641-644.
LI L,TANG Y Q.Expressions of hypoxia-inducib le factor-1αand vascular endothelia l growthfactor in retina of streptozotocin induced d iabetic rats［J］.J Fourth Mil Med Univ,2007，28(7):641-644.
［11］　LAKK M,DENES V,KOVACS K,HIDEG O,SZABO B F,GABRIEL R.Pituitary adenylate cyclase-activating peptide (PACAP),a novel secretagogue,regulates secreted morphogens in newborn rat retina［J］.Invest Ophthalmol Vis Sci,2017,58(1):565-572.
［12］　D’AMICO A G,MAUGERI G,RASA D M,BUCOLO C,SACCONE S,FEDERICO C,et al.Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration［J］.Peptides,2017,97:64-69.
［13］　SEKI T,ITOH H,NAKAMACHI T,SHIODA S.Suppression of ganglion cell death by pacap following optic nerve transection in the rat［J］.J Mol Neurosci,2008,36(1-3):57-60.
［14］　汪书越.TRPC通道在大鼠视网膜的表达及TRPC6对慢性高眼压RGC凋亡的作用［D］.上海：复旦大学,2014.
WANG S Y.Expression of rat channel in rat retina and effect of TRPC6 on apoptosis of chronic high intraocular pressure RGC［D］.Shanghai：Fudan University,2014.
［15］　WANG X,TENG L,LI A,GE J,LATIES A M,ZHANG X.TRPC6 channel protects retinal ganglion cells in a rat model of retinal ischemia/reperfusion-induced cell death［J］.Invest Ophthalmol Vis Sci,2010,51(11):5751-5758.
［16］　SHIRAKAWA H,KATSUMOTO R,IIDA S,MIYAKE T,HIGUCHI T,NAGASHIMA T,et al.Sphingosine-1-phosphate induces Ca(2+) signaling and CXCL1 release via TRPC6 channel in astrocytes［J］.Glia,2017,65(6):1005-1016.
［17］　KO A R,KANG T C.TRPC6-mediated ERK1/2 phosphorylation prevents dentate granule cell degeneration via inhibiting mitochondrial elongation［J］.Neuropharmacology,2017,121:120-129.
［18］　张礼均,冯华.星形胶质细胞活化后瞬时受体电位通道6在TBI中的作用［J］.重庆医学,2017,46(18):2456-2458.
ZHANG L J,FENG H.Role of transient receptor potential channel 6 in TBI after astrocyte activation ［J］.Chongqing Med,2017,46 (18):2456-2458.
［19］　侯常青,庹必光.瞬时受体电位通道和消化系肿瘤的关系研究进展［J］.中国比较医学杂志,2019,29(6):129-134.
HOU C Q,TUO B G.Research progress on the relationship between transient receptor potential channels and digestive system tumors ［J］.Chin J Comparat Med,2019,29(6):129-134.

备注/Memo

备注/Memo:
N/A
更新日期/Last Update: 2020-07-05